Year To Quarter End Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7295281

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
71,512,000 JPY
26,861,000 JPY
Comprehensive income
71,512,000 JPY
26,861,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
71,512,000 JPY
26,861,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.